Journal
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
Volume 165, Issue 5, Pages 649-652Publisher
SPRINGER
DOI: 10.1007/s10517-018-4233-4
Keywords
type 2 diabetes mellitus; Afobazole; metformin; streptozotocin
Categories
Ask authors/readers for more resources
Using the streptozotocin model of type 2 diabetes mellitus in Wistar rats, we compared antidiabetic activity of anxiolytic Afobazole with that of metformin. Afobazole in a dose of 10 mg/kg reduced streptozotocin-induced hyperglycemia and polyphagia and prevented accumulation of malonic dialdehyde, being not inferior to metformin in a dose of 300 mg/kg, and was even more effective than metformin in body weight recovery, elimination of polydipsia, and preservation of these effects after treatment withdrawal.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available